关注
Giorgio Vittorio Scagliotti
Giorgio Vittorio Scagliotti
在 unito.it 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma
WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ...
Journal of thoracic oncology 6 (2), 244-285, 2011
59752011
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
GV Scagliotti, P Parikh, J Von Pawel, B Biesma, J Vansteenkiste, ...
Journal of clinical oncology 26 (21), 3543-3551, 2008
42972008
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ...
New England Journal of Medicine 371 (23), 2167-2177, 2014
36002014
Lung cancer: current therapies and new targeted treatments
FR Hirsch, GV Scagliotti, JL Mulshine, R Kwon, WJ Curran, YL Wu, ...
The Lancet 389 (10066), 299-311, 2017
28752017
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
JP Pignon, H Tribodet, GV Scagliotti, JY Douillard, FA Shepherd, ...
Database of Abstracts of Reviews of Effects (DARE): Quality-Assessed Reviews …, 2008
28412008
Gefitinib in combination with paclitaxel and carboplatin in advanced non–small-cell lung cancer: a phase III trial—INTACT 2
RS Herbst, G Giaccone, JH Schiller, RB Natale, V Miller, C Manegold, ...
Journal of Clinical Oncology 22 (5), 785-794, 2004
23382004
Gefitinib in combination with gemcitabine and cisplatin in advanced non–small-cell lung cancer: a phase III trial—INTACT 1
G Giaccone, RS Herbst, C Manegold, G Scagliotti, R Rosell, V Miller, ...
Journal of Clinical Oncology 22 (5), 777-784, 2004
23082004
Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer …
DH Henry, L Costa, F Goldwasser, V Hirsh, V Hungria, J Prausova, ...
J Clin Oncol 29 (9), 1125-1132, 2011
14152011
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer
GV Scagliotti, F De Marinis, M Rinaldi, L Crino, C Gridelli, S Ricci, ...
Journal of clinical oncology 20 (21), 4285-4291, 2002
12262002
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies
G Scagliotti, N Hanna, F Fossella, K Sugarman, J Blatter, P Peterson, ...
The oncologist 14 (3), 253-263, 2009
9082009
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series
S Bovio, A Cataldi, G Reimondo, P Sperone, S Novello, A Berruti, ...
Journal of endocrinological investigation 29, 298-302, 2006
8632006
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non–small-cell lung cancer
GV Scagliotti, R Fossati, V Torri, L Crino, G Giaccone, G Silvano, ...
Journal of the National Cancer Institute 95 (19), 1453-1461, 2003
8192003
The 2021 WHO classification of lung tumors: impact of advances since 2015
AG Nicholson, MS Tsao, MB Beasley, AC Borczuk, E Brambilla, ...
Journal of Thoracic Oncology 17 (3), 362-387, 2022
7112022
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
NSCLC Meta-analyses Collaborative Group
The Lancet 375 (9722), 1267-1277, 2010
7012010
Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC
C Rolfo, PC Mack, GV Scagliotti, P Baas, F Barlesi, TG Bivona, RS Herbst, ...
Journal of thoracic oncology 13 (9), 1248-1268, 2018
6342018
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open …
AT Shaw, TM Kim, L Crinò, C Gridelli, K Kiura, G Liu, S Novello, A Bearz, ...
The Lancet Oncology 18 (7), 874-886, 2017
5742017
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy …
P Maione, F Perrone, C Gallo, L Manzione, FV Piantedosi, S Barbera, ...
Journal of Clinical Oncology 23, 6865-6872, 2005
5662005
Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase
P Ceppi, M Volante, S Saviozzi, I Rapa, S Novello, A Cambieri, ...
Cancer 107 (7), 1589-1596, 2006
5392006
Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer
G Scagliotti, S Novello, J von Pawel, M Reck, JR Pereira, M Thomas, ...
J Clin Oncol 28 (11), 1835-1842, 2010
5152010
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
P Ceppi, M Volante, S Novello, I Rapa, KD Danenberg, PV Danenberg, ...
Annals of Oncology 17 (12), 1818-1825, 2006
5002006
系统目前无法执行此操作,请稍后再试。
文章 1–20